This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
FDA chief Marty Makary and new CBER Director Vinay Prasad said that future Covid...
Tourmaline Bio's experimental drug for atherosclerotic heart disease reduced mar...
Plus, news about Beckley Psytech, Regenxbio, Blueprint Medicines, VantAI, NovelM...
The Department of Health and Human Services provided the first details for how i...
The Department of Health and Human Services provided the first details for how i...
Calibrate has replaced its CEO and made several other executive changes, Endpoin...
Healthcare is figuring out what AI to use in a crowded market. Optura says it ca...
Telehealth is becoming more comprehensive than a quick online visit. Portlan...
Biotech execs don’t quite know what to make of the new FDA chief. There’s been p...
Pfizer is set to enter the heated VEGF bispecific arena. The New York drug g...
A longevity startup called Retro Biosciences is working on personalized blood di...
Regeneron is doubling down on its genetics research ambitions by agreeing to buy...
AbbVie's defense of its megablockbuster Humira may go down in the history books ...
Boehringer Ingelheim claimed two Phase 3 wins for its PDE4 inhibitor in fibrotic...
Researchers have devised another way to insert large genes into precise spots in...
In gene editing, scientific milestones and promising early data do not always me...